Sims JR, Zimmer JA, Evans CD, Lu M, et al. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA 2023 Jul 17:e2313239. doi: 10.1001/jama.2023.13239.
PMID: 37459141